The Medical Device Testing Services Market Size accounted for USD 8.6 Billion in 2023 and is estimated to achieve a market size of USD 21.3 Billion by 2032 growing at a CAGR of 10.6% from 2024 to 2032.
Medical Device Testing Services Market Highlights
- Global medical device testing services market revenue is poised to garner USD 21.3 billion by 2032 with a CAGR of 10.6% from 2024 to 2032
- Asia-Pacific medical device testing services market share accounted for over 42% shares in 2023
- According to the a recent statistics, unsafe medical devices have caused 1.7 million injuries worldwide and roughly 83,000 deaths in the last 12 years
- Asia-Pacific medical device testing services market growth will record substantial CAGR from 2024 to 2032
- Based on service, microbiology & sterility testing captured over 36% of the overall market share in 2023
- Among phases, clinical occupied more than 70% of the market share from 2024 to 2032
- Surging technological advancements in device testing is a popular medical device testing services market trend that is fueling the industry demand
The market for medical device testing services is quickly expanding, driven by rising demand for medical device quality and safety. The preclinical phase of medical device development is a vital stage in which devices are examined to guarantee compliance with regulatory requirements and safety for human usage. Medical device testing services are critical in this process because they ensure that medical devices such as MRI machines, defibrillators, and other equipment work properly and are free of faults.
Medical device testing encompasses a variety of operations, including hardware and software verification and validation. Hardware testing entails evaluating the device's physical components, such as mechanical functionality and electrical performance. In contrast, software testing entails testing the device's software components, such as its programming and algorithms. Medical device testing also encompasses certificate, manufacturing, and R&D testing.
Several factors contribute to the rising need for medical device testing, including the increasing complexity of medical devices, the requirement for faster time-to-market, and the growing relevance of regulatory compliance. Medical device makers are under pressure to guarantee that their products meet stringent regulatory criteria, such as those imposed by the FDA in the United States and the European Union's Medical Device Regulations. Medical device testing service providers assist manufacturers in meeting these standards by providing a range of services such as testing, validation, and certification.
Global Medical Device Testing Services Market Dynamics
Market Drivers
- Rising number of stringent government regulations
- Increasing number of chronic and elderly patients
- Growing demand for verification and validation of medical devices
- Rapid advancements in medical technologies
Market Restraints
- Dynamic rules and regulations across different regions
- Lack of skilled professionals and testing facilities
Market Opportunities
- Robust growth of medical devices industries in emerging nations
- Advent of AI and IoT in medical device testing service industry
Medical Device Testing Services Market Report Coverage
Market |
Medical Device Testing Services Market
|
Medical Device Testing Services Market Size 2022 |
USD 8.6 Billion |
Medical Device Testing Services Market Forecast 2032 |
USD 21.3 Billion
|
Medical Device Testing Services Market CAGR During 2024 - 2032 |
10.6% |
Medical Device Testing Services Market Analysis Period |
2020 - 2032 |
Medical Device Testing Services Market Base Year
|
2022 |
Medical Device Testing Services Market Forecast Data |
2024 - 2032 |
Segments Covered |
By Service, By Phase, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Nelson Labs, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, Intertek Group PLC, North American Science Associates, Inc., WuXiAppTec Group, and Pace Analytical Services, LLC.
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Medical Device Testing Services Market Insights
The medical device testing market is driven by the increasing complexity of medical devices, which requires rigorous testing to ensure their safety and effectiveness. The rise of drug-device combinations, personalized medication, and artificial intelligence (AI) in medical devices has led to a more complex ecosystem. As a result, medical devices must undergo extensive testing in augmented conditions to obtain marketing approval. Conducting these tests in-house can be time-consuming, costly, and labor-intensive, making it more practical for companies to outsource these services to specialized testing providers. This trend is expected to drive the growth of the medical device testing services market as companies seek to streamline their testing processes and reduce costs.
The need for outsourcing medical device testing services is also driven by the growing demand for in-vitro tests, which are becoming increasingly popular as a replacement for traditional in-vivo tests that require animal testing. Many Contract Research Organizations (CROs) are developing novel in-vitro test methods that can mimic the human body's response to medical devices. The development of standardized in-vitro test approaches for sensitization, cytotoxicity, and irritation is also expected to support the growth of the industry. These tests are essential for ensuring the safety and efficacy of medical devices, and the increasing adoption of in-vitro testing is expected to drive the growth of the medical device testing services market. Additionally, the growing demand for real-time patient monitoring and personalized medicine is also driving the growth of the market, as medical devices must be designed to meet the specific needs of individual patients.
Medical Device Testing Services Market Segmentation
The worldwide market for medical device testing services is split based on product, type, and geography.
Medical Device Testing Services Market By Service
- Biocompatibility Tests
- Orthopedic Device's Biocompatibility Tests
- Dental Implant Devices' Biocompatibility Tests
- Dermal Filler's Biocompatibility Tests
- General Surgery Implantation Devices Biocompatibility Tests
- Neurosurgical Implantation Devices Biocompatibility Tests
- Ophthalmic Implantation Device's Biocompatibility Tests
- Others
- Chemistry Test
- Analytical method development and validation
- Chemical characterization (E&L)
- Toxicological Risk Assessment and consulting
- Microbiology & Sterility Testing
- Bio-Burden Determination
- Pyrogen and Endotoxin Testing
- Sterility Test and Validation
- Anti-microbial Activity Testing
- Other Services
- Package Validation
According to the medical device testing services industry analysis, microbiology & sterility testing sub-segment grabbed the maximum revenue in 2023 and is expected to do so in the coming years. Microbiology and sterility testing are performed to eliminate or reduce the risk of contamination in the manufacturing process, which could lead to infections in patients or product users. On the other hand, chemistry test is one of the sub-segments that is anticipated to witness fastest growth rate during the projected timeframe from 2024 to 2032.
Medical Device Testing Services Market By Phase
- Preclinical
- Antimicrobial Wound Dressings
- Medical Coatings
- Others
- Clinical
As per medical device testing services market forecast, the clinical sub-segment accounted for over 2/3rd of the total market shares in 2023 and is likely to maintain this trend over the estimated timeframe of 2024 to 2032. Additionally, it is projected that during the forecast period this segment will expand the fastest. The cost of medical device testing services for the clinical stage is significantly greater than for the preclinical stage, which is a crucial element in deciding the clinical stage's greatest market.
Medical Device Testing Services Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Medical Device Testing Services Market Regional Analysis
The medical device testing services market is led by the Asia-Pacific region, driven by the growing trend of outsourcing in countries such as India and China. Contract Research Organizations (CROs) are investing heavily in these emerging nations due to the lower cost and availability of skilled labor. The Asia-Pacific region is expected to continue its dominance in the market, driven by the increasing demand for medical device testing services.
The North America region is expected to be the second-largest medical device testing market, with significant growth anticipated during the forecast period. This is attributed to the region's reputation as a hub for complex, high-end, and reliable medical devices. Many CROs have established a strong presence in the region, offering a comprehensive range of testing services to businesses.
The Europe region is led by the EU5 nations (Germany, Spain, UK, France, and Italy), where the demand for cost-cutting and increasing complexity in product design is driving the growth of the medical device testing services market. The region is expected to experience significant growth as companies look to streamline their testing processes and reduce costs while ensuring the quality and safety of their medical devices.
Medical Device Testing Services Market Players
Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the medical device testing services market are Nelson Labs, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, Intertek Group PLC, North American Science Associates, Inc., WuXiAppTec Group, and Pace Analytical Services, LLC.
CHAPTER 1. Industry Overview of Medical Device Testing Services Market
1.1. Definition and Scope
1.1.1. Definition of Medical Device Testing Services
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Medical Device Testing Services Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Medical Device Testing Services Market By Service
1.2.3. Medical Device Testing Services Market By Phase
1.2.4. Medical Device Testing Services Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Medical Device Testing Services Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Medical Device Testing Services Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Medical Device Testing Services Market By Service
5.1. Introduction
5.2. Medical Device Testing Services Revenue By Service
5.2.1. Medical Device Testing Services Revenue (USD Million) and Forecast, By Service, 2020-2032
5.2.2. Biocompatibility Tests
5.2.2.1. Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.2. Cardiovascular Device's Biocompatibility Tests
5.2.2.2.1. Cardiovascular Device's Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.3. Dental Implant Devices' Biocompatibility Tests
5.2.2.3.1. Dental Implant Devices' Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.4. Dermal Filler's Biocompatibility Tests
5.2.2.4.1. Dermal Filler's Biocompatibility Tests Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.5. General Surgery Implantation Devices Biocompatibility Tests
5.2.2.5.1. General Surgery Implantation Devices Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.6. Neurosurgical Implantation Devices Biocompatibility Tests
5.2.2.6.1. Neurosurgical Implantation Devices Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.7. Ophthalmic Implantation Device's Biocompatibility Tests
5.2.2.7.1. Ophthalmic Implantation Device's Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.8. Orthopedic Device's Biocompatibility Tests
5.2.2.8.1. Orthopedic Device's Biocompatibility Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.2.9. Others
5.2.2.9.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Chemistry Test
5.2.3.1. Chemistry Test Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.2. Analytical method development and validation
5.2.3.2.1. Analytical method development and validation Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.3. Chemical characterization (E&L)
5.2.3.3.1. Chemical characterization (E&L) Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3.4. Toxicological Risk Assessment and consulting
5.2.3.4.1. Toxicological Risk Assessment and consulting Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Microbiology & Sterility Testing
5.2.4.1. Microbiology & Sterility Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.2. Bioburden Determination
5.2.4.2.1. Bioburden Determination Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.3. Pyrogen & Endotoxin Testing
5.2.4.3.1. Pyrogen & Endotoxin Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.4. Sterility Test & Validation
5.2.4.4.1. Sterility Test & Validation Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.5. Antimicrobial Testing
5.2.4.5.1. Antimicrobial Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4.6. Others
5.2.4.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Package Validation
5.2.5.1. Package Validation Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Medical Device Testing Services Market By Phase
6.1. Introduction
6.2. Medical Device Testing Services Revenue By Phase
6.2.1. Medical Device Testing Services Revenue (USD Million) and Forecast, By Phase, 2020-2032
6.2.2. Preclinical
6.2.2.1. Preclinical Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Clinical
6.2.3.1. Clinical Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Medical Device Testing Services Market By Country
7.1. North America Medical Device Testing Services Market Overview
7.2. U.S.
7.2.1. U.S. Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
7.2.2. U.S. Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
7.3. Canada
7.3.1. Canada Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
7.3.2. Canada Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Medical Device Testing Services Market By Country
8.1. Europe Medical Device Testing Services Market Overview
8.2. U.K.
8.2.1. U.K. Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
8.2.2. U.K. Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
8.3. Germany
8.3.1. Germany Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
8.3.2. Germany Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
8.4. France
8.4.1. France Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
8.4.2. France Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
8.5. Spain
8.5.1. Spain Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
8.5.2. Spain Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
8.6.2. Rest of Europe Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Medical Device Testing Services Market By Country
9.1. Asia Pacific Medical Device Testing Services Market Overview
9.2. China
9.2.1. China Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.2.2. China Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.3. Japan
9.3.1. Japan Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.3.2. Japan Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.4. India
9.4.1. India Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.4.2. India Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.5. Australia
9.5.1. Australia Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.5.2. Australia Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.6. South Korea
9.6.1. South Korea Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.6.2. South Korea Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
9.7.2. Rest of Asia-Pacific Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Medical Device Testing Services Market By Country
10.1. Latin America Medical Device Testing Services Market Overview
10.2. Brazil
10.2.1. Brazil Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
10.2.2. Brazil Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
10.3. Mexico
10.3.1. Mexico Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
10.3.2. Mexico Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
10.4.2. Rest of Latin America Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Medical Device Testing Services Market By Country
11.1. Middle East & Africa Medical Device Testing Services Market Overview
11.2. GCC
11.2.1. GCC Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
11.2.2. GCC Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
11.3. South Africa
11.3.1. South Africa Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
11.3.2. South Africa Medical Device Testing Services Revenue (USD Million) and Forecast By Phase, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
11.4.2. Rest of Middle East & Africa Medical Device Testing Services Revenue (USD Million) and Forecast By Service, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Medical Device Testing Services Market
12.1. Medical Device Testing Services Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Medical Device Testing Services Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Nelson Labs
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2023
13.1.3.2. Nelson Labs 2023 Medical Device Testing Services Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Toxikon, Inc.
13.3. American Preclinical Services LLC
13.4. SGS SA
13.5. Charles River Laboratories International, Inc.
13.6. Eurofins Scientific, LLC
13.7. Sterigenics International LLC
13.8. Intertek Group PLC
13.9. North American Science Associates, Inc.
13.10. WuXiAppTec Group
13.11. Pace Analytical Services, LLC